(1) Resignation of directors; and (2) change in composition of strategy committee
Filed with HKEX · Stock code 2591 · · 2 pages · English
Summary by 6ix AI
Guangzhou Innogen Pharmaceutical Group Co., Ltd. reports the resignation of two directors and a change in the composition of its Strategy Committee. Ms. Xu Wenjie has resigned as an executive Director and member of the Strategy Committee, while Mr. Heng Lei has resigned as a non-executive Director, both effective from a future date. Mr. Huang Bing has been appointed to the Strategy Committee following Ms. Xu's resignation.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/1-resignation-of-directorsandx3b-and-2-change-in-composition-of-strategy-committee
Guangzhou Innogen Pharmaceutical Group Co Ltd on 6ix
Earlier from Guangzhou Innogen Pharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Interim Report 2026
- Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa
- Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
Later from Guangzhou Innogen Pharmaceutical
- List of directors and their roles and functions
- Voluntary announcement - appointment of senior management
Follow Guangzhou Innogen Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Innogen Pharmaceutical